Keymed evaluates CM-310 in phase II for chronic rhinosinusitis with nasal polyposis May 10, 2021 No Comments
Mesoblast reports 60-day results on remestemcel-L in COVID-19 related ARDS April 30, 2021 No Comments
Phase II study application for FB-704A in severe asthma receives approval in Taiwan April 21, 2021 No Comments
RSS